Literature DB >> 21480336

New staging system and a registry for perihilar cholangiocarcinoma.

Michelle L Deoliveira1, Richard D Schulick, Yuji Nimura, Charles Rosen, Gregory Gores, Peter Neuhaus, Pierre-Alain Clavien.   

Abstract

Perihilar cholangiocarcinoma is one of the most challenging diseases with poor overall survival. The major problem for anyone trying to convincingly compare studies among centers or over time is the lack of a reliable staging system. The most commonly used system is the Bismuth-Corlette classification of bile duct involvement, which, however, does not include crucial information such as vascular encasement and distant metastases. Other systems are rarely used because they do not provide several key pieces of information guiding therapy. Therefore, we have designed a new system reporting the size of the tumor, the extent of the disease in the biliary system, the involvement of the hepatic artery and portal vein, the involvement of lymph nodes, distant metastases, and the volume of the putative remnant liver after resection. The aim of this system is the standardization of the reporting of perihilar cholangiocarcinoma so that relevant information regarding resectability, indications for liver transplantation, and prognosis can be provided. With this tool, we have created a new registry enabling every center to prospectively enter data on their patients with hilar cholangiocarcinoma (www.cholangioca.org). The availability of such standardized and multicenter data will enable us to identify the critical criteria guiding therapy. 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21480336     DOI: 10.1002/hep.24227

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  101 in total

Review 1.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  [Klatskin tumors: rational diagnostics and staging].

Authors:  U W Denzer; T Rösch
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

3.  Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.

Authors:  Yaoting Chen; Huiqing Li; Xiongying Jiang; Dong Chen; Jiayan Ni; Hongliang Sun; Jianghong Luo; Herui Yao; Linfeng Xu
Journal:  Eur Radiol       Date:  2016-01-28       Impact factor: 5.315

4.  Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver Transplantation.

Authors:  Vijayadershan Muppidi; Sreenath Meegada; James D Eason; Satheesh P Nair; Rajanshu Verma
Journal:  Cureus       Date:  2020-11-24

5.  Robotic Resection of a Type IIIB Klatskin Tumor.

Authors:  Iswanto Sucandy; Sharona Ross; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2021-03-16       Impact factor: 3.452

6.  Cholangiocarcinoma: another masquerader in the making?

Authors:  Karthik Gnanapandithan; Satya Allaparthi; Thomas Ukena; Curuchi Anand
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 7.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

8.  Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; David van Klaveren; Robert J Coelen; C Yung Nio; Peter J Allen; Marc G Besselink; Olivier R Busch; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Thomas M van Gulik; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2018-04-06       Impact factor: 6.113

Review 9.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

10.  Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Rong-Xing Zhou; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Fei Liu; Nan-Sheng Cheng; Fu-Yu Li
Journal:  J Gastrointest Surg       Date:  2018-08-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.